ARTICLE
|
doi:10.20944/preprints202410.0895.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
cancer; NSCLC; EGFR mutations; TKIs; CRISPR
Online: 11 October 2024 (13:30:15 CEST)
REVIEW
|
doi:10.20944/preprints202405.0212.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Hepatocellular carcinoma (HCC); systemic therapies; bridging; liver transplantation (LT); Tyrosine Kinase Inhibitors (TKIs); Immune Checkpoint Inhibitors (ICIs)
Online: 6 May 2024 (04:52:05 CEST)
ARTICLE
|
doi:10.20944/preprints202403.1686.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
lung adenocarcinoma; drug-tolerant persister (DTP) cells; intrinsic resistance; tyrosine kinase inhibitors (TKIs); erlotinib; osimertinib; senescent cells; CD74
Online: 28 March 2024 (12:16:57 CET)
REVIEW
|
doi:10.20944/preprints202305.0122.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Non-small cell lung cancer (NSCLC); EGFR; Tyrosine kinase inhibitors (TKIs); Uncommon mutation; Compound mutation; Intracranial activity; Immunotherapy
Online: 3 May 2023 (09:29:08 CEST)